3 Exciting Biotech Stocks to Buy Right Now
Although many think that DNA wasn't discovered until the 1950s, that was only when its three-dimensional double-helix structure was first recognized. The genetic molecule itself was first identified back in 1869. And today, some of the most exciting publicly traded biotech companies are capitalizing on our ever-growing ability to map and manipulate genes.
Intellia Therapeutics (NASDAQ: NTLA), Beam Therapeutics (NASDAQ: BEAM), and Twist Bioscience (NASDAQ: TWST) are all carving niches for themselves in that industry, adding to what we know about the human genome and using that knowledge in an attempt to fight some of the most stubborn diseases. And investors are paying attention -- all three stocks are up by more than 300% in the past year.
Source Fool.com
